ABTA President and CEO Ralph A. DeVitto is retiring next February, after serving the ABTA for seven years. His legacy highlights remarkable achievements, including significantly increasing the organization’s revenue resulting in a substantial boost in research funding and patient resources dedicated to combating brain tumors. Ralph strengthened the ABTA’s mission and broadened its reach to support countless patients, caregivers, families, researchers and stakeholders in the brain tumor community.
We share our deepest gratitude to Ralph for his transformative leadership, integrity, and unwavering commitment in the fight against brain tumors.
Watch his impact through the years!
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.
